The company is significantly advanced this course of an new treatment for ATTR-CM, leveraging the compound. Early trial information suggests promising outcomes for patients affected from this serious condition. The https://attr-cm760313.digitollblog.com/42063547/company-improves-attr-cm-treatment-through-attruby